Company intelligence / Profile preview

GeneFrontier

Kashiwa, Chiba, Japan
Ownership
Private
Employees
~30
Development stage
Other
01

Overview

GeneFrontier is a Japanese biotechnology company that specializes in advanced protein synthesis and antibody discovery technologies. The company's flagship platform, PUREfrex, is a reconstituted cell-free protein synthesis system that enables the rapid production of high-purity proteins without the need for living cells. GeneFrontier also offers the ADLib system, a unique technology for generating monoclonal antibodies through the diversification of immunoglobulin genes in chicken DT40 cells. As a subsidiary of Kaneka Corporation, the company provides essential tools and contract research services to pharmaceutical companies and academic researchers worldwide. Their expertise spans from protein engineering to the development of specialized reagents for drug discovery and diagnostics.

Modalities
ProteinMonoclonal antibodyPeptides
Industry
Drug Discovery Services
02

Partnerships

Chiome BioscienceKaneka

Beyond the preview

Go deeper on GeneFrontier.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneFrontier.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call